NIAID animation explains the ever-changing nature of influenza viruses.
Learn how immunizing a critical portion of a community protects most members of the community.
Volunteer for NIAID-funded clinical studies related to vaccines on ClinicalTrials.gov.
Vaccines provide safe, cost-effective, and efficient means of preventing illness, disability, and death from infectious diseases. NIAID conducts and supports research on new and improved vaccines and is a worldwide leader in the basic immunology research that underpins all vaccine research and development.
Sequential Immunization with VSV-Based Lassa and Ebola Vaccines Does Not Diminish Protection in Monkeys, NIAID Study Finds—Nov. 14 2014
NIH Begins Early Human Clinical Trial of VSV Ebola Vaccine—Oct. 22, 2014
Media Availability: NIH Grants License Agreement for Candidate Ebola Vaccines—Oct. 15, 2014
Candidate H7N9 Avian Flu Vaccine Works Better with Adjuvant—Oct. 7, 2014
Gut Bacteria Boost Immune Response to Flu Vaccine—Oct. 1, 2014
Two-Dose Rotavirus Vaccine Regimen Initiated During Newborn Period Prevents Rotavirus Diarrhea
Rabies Vaccine Protects Nonhuman Primates against Deadly Ebola Virus
Flu Shots No More? NIAID Grantees Use New Skin Patches to Deliver Flu Vaccine in Mice
Read More: All Vaccine News Releases | News From NIAID-Supported Institutions
Program Announcement: Information about Grants for Research to Advance Vaccine Safety (R01 and R21)
Overcoming Challenges in Staphylococcus aureus Vaccine Development - Meeting Summary, June 7, 2013 (PDF)
Jordan Report: Accelerated Development of Vaccines 2012
Last Updated November 14, 2014